桂林莱茵生物科技股份有限公司 证券代码：002166 证券简称：莱茵生物 公告编号：2025-048 桂林莱茵生物科技股份有限公司 关于部分限制性股票回购注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1 桂林莱茵生物科技股份有限公司 特别提示： 1、桂林莱茵生物科技股份有限公司（以下简称"公司"、"莱茵生物"） 本次回购注销的限制性股票总数为1.41万股，占回购注销前公司总股本的 0.0019%。 2、截至本公告披露日，上述股份已在中国证券登记结算有限责任公司深圳 分公司办理完毕注销手续，公司总股本由 741,623,525 股变更为 741,609,425 股。 一、公司限制性股票激励计划已履行的相关审批程序 （一）2022年9月13日，公司第六届董事会第十六次会议及第六届监事会第 十四次会议审议通过了《关于公司<2022年限制性股票激励计划（草案）>及摘 要的议案》《关于公司<2022年限制性股权激励计划实施考核管理办法>的议案》 等相关议案。公司独立董事就本次股权激励计划相关事项发表了明确同意的独立 意见。北京德恒律师事务所出具了《北京 ...

Group 1 - The core incident involved an explosion in a drying workshop of Rhine Biotech, resulting in 1 death, 3 serious injuries, and 4 minor injuries [2] - The company activated its emergency response plan and is cooperating with government authorities for rescue and investigation efforts [2] - The preliminary assessment of property damage from the incident is approximately 2 million yuan, but it is stated that the accident will not have a significant adverse impact on the company's future operations [5] Group 2 - Rhine Biotech specializes in the production and operation of natural health products, with stable revenue growth reported: 1.401 billion yuan in 2022, 1.494 billion yuan in 2023, and 1.772 billion yuan in 2024 [5] - The company has been actively conducting employee training, totaling 14,738 hours across various training programs in 2024 [6] - Recent allegations have surfaced against the actual controller of Rhine Biotech, Qin Benjun, regarding stock price manipulation, leading to administrative penalties including a 5-year market ban and fines totaling 276.36 million yuan [10]

Group 1 - The explosion incident at Rhine Biotech occurred on August 21, 2025, resulting in 1 death, 3 serious injuries, and 4 minor injuries [3][4] - The company has initiated an emergency response plan and is cooperating with government authorities for rescue and investigation efforts [3][4] - Preliminary estimates indicate property damage of over 2 million yuan due to the explosion in the drying workshop [3] Group 2 - Rhine Biotech is a leading enterprise in the global plant extraction industry and the first listed company in China's plant extraction sector [6] - The company's stock price experienced a sharp decline following the incident, closing at 8.26 yuan per share with a market capitalization of 6.1 billion yuan [6] - The company asserts that the incident will not have a significant adverse impact on its future operations and plans to enhance safety management measures [3]

Core Viewpoint - An explosion occurred at a drying workshop of Guilin Rhein Biotech Co., Ltd., resulting in one death and several injuries, with the company cooperating with authorities for investigation and recovery efforts [1][2] Incident Details - The explosion took place on August 21 at approximately 5:40 AM in a drying workshop, which is part of the company's plant extraction production process [1] - The incident resulted in one fatality, three serious injuries, and four minor injuries among the employees [1][2] - Initial estimates indicate property damage of over 2 million yuan (approximately 0.29 million USD) [1] Company Response - The company activated its emergency response plan immediately after the incident, forming a leadership group to manage on-site emergency actions and assist in rescue operations [1] - The company expressed condolences for the deceased employee and extended sympathies to the injured and their families, reflecting a commitment to employee welfare [2]

Economic Information - According to the China Index Academy, as of August 2025, the debt restructuring and reorganization of 20 distressed real estate companies will exceed 12,000 billion RMB, significantly impacting the real estate sector [2] - As of August 13, the national pig price was 14.25 RMB/kg, down 1.32% from August 6, with the pig-to-grain price ratio at 5.94, a decrease of 1.33% [2] Company Alerts - Jishi Media reported a net loss of 232 million RMB in the first half of the year [5] - Dameng Data had two directors investigated within three days [5] - Kanglong Chemical's net profit for the first half of the year was 701 million RMB, a decrease of 37% year-on-year [5] - Yunmei Energy reported a net loss of 163 million RMB in the first half of the year [5] - Zhuosheng Microelectronics experienced a net loss of 147 million RMB in the first half, marking a transition from profit to loss [5] - Penghui Energy reported a net loss of 88.23 million RMB in the first half, also transitioning from profit to loss [5] - Aoxin Security reported a net loss of 356 million RMB in the first half [5] - Anyuan Coal Industry reported a net loss of 290 million RMB in the first half [5] - Guangsheng Tang reported a net loss of 66.6881 million RMB in the first half [5] - Yiyuan Lithium Energy's net profit decreased by 24.9% year-on-year in the first half [5] - Zhongtian Rocket's net profit decreased by 80.74% year-on-year in the first half [5] - Jianjie Industrial reported a net profit of 48.8658 million RMB in the first half, down 44.90% year-on-year [5] - Nanjing Chemical Fiber reported a net loss of 88.9317 million RMB in the first half [5] - Sanwei Xinan reported a net loss of 29.3858 million RMB in the first half [5] - Taiping Bird reported a net profit of 77.7116 million RMB in the first half, down 54.61% year-on-year [5] - Aerospace Power reported a net loss of 73.1243 million RMB in the first half [5] - Renhe Pharmaceutical's subsidiary product ULook brain-machine interaction smart glasses has not generated sales revenue [5] - Rhein Biotech experienced a safety incident resulting in one death and three serious injuries [5] - Guangfeng Technology's arbitration ruling is expected to reduce the consolidated profit for 2025 by approximately 91 million RMB [5] Overseas Alerts - The three major U.S. stock indices experienced slight declines, with the S&P 500 down 0.4%, marking its fifth consecutive day of decline [4] - The U.S. Department of Justice plans to investigate Federal Reserve Governor Lisa Cook and has urged Fed Chairman Powell to dismiss her [4] - According to the International Copper Study Group, a surplus of 36,000 tons in the global refined copper market is expected by June 2025 [4]

Core Viewpoint - On August 21, 2025, a drying equipment explosion occurred at Guilin Rhein Biotechnology Co., Ltd., resulting in 1 death and multiple injuries. The company is cooperating with government authorities for emergency response and investigation [1][5]. Incident Summary - The explosion took place in a drying workshop, leading to 1 fatality, 3 serious injuries, and 4 minor injuries. The company activated its emergency response plan and formed a leadership group for on-site management [1][5]. - Initial estimates indicate property damage of approximately 2 million yuan (around 0.29 million USD) due to the incident. However, the company stated that this accident would not significantly impact its future operations [1][5]. Company Profile - Guilin Rhein Biotechnology is a leading enterprise in the global plant extraction industry and the first listed company in China's plant extraction sector. The company specializes in the research, production, and sales of natural health products [5]. Financial Performance - In the first quarter of 2025, the company reported revenue of 444 million yuan (approximately 63.5 million USD), representing a year-on-year increase of 30.21%. The net profit attributable to shareholders was 30.8 million yuan (around 4.4 million USD), up 14.95% year-on-year [6]. Stock Market Reaction - Following the incident, the company's stock price fell by 4.44%, closing at 8.18 yuan per share, with a total market capitalization of 6.1 billion yuan (approximately 861 million USD) [7][8].

【"一公里外听到爆炸声" #广西桂林一公司设备爆炸1死7伤# 涉事企业官网已变灰】#广西一公司回应设 备爆炸1死7伤#8月21日，广西桂林临桂区一公司车间发生设备爆炸，造成1死7伤。@新京报 记者核实 获悉，事发公司为广西桂林莱茵生物（维权）科技股份有限公司。周边居民称，事发车间位于厂区内 部，凌晨五点多居民曾在附近听到爆炸声。莱茵生物总部工作人员告诉记者，目前公司仍在正常经营。 该工作人员称，遇难者和伤者的安置工作由专人负责，事故原因仍在调查中。 ...

8月21日，广西桂林临桂区一公司车间发生设备爆炸，造成1死7伤。记者核实获悉，事发公司为广西桂 林莱茵生物（002166）科技股份有限公司。有周边居民称，事发车间位于厂区内部，凌晨五点多居民曾 在附近听到爆炸声。莱茵生物总部工作人员告诉记者，目前公司仍在正常经营。该工作人员称，遇难者 和伤者的安置工作由专人负责，事故原因仍在调查中。 ...

证券日报网讯莱茵生物8月21日在互动平台回答投资者提问时表示，公司主营产品以功能性成分为主， 暂无规模化生产天然色素的计划。 （文章来源：证券日报） ...

桂林莱茵生物科技股份有限公司 证券代码：002166 证券简称：莱茵生物 公告编号：2025-042 桂林莱茵生物科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 桂林莱茵生物科技股份有限公司（以下简称"公司"）关于召开第七届董事会第 六次会议的通知于 2025 年 8 月 17 日以短信、即时通讯工具及电子邮件的方式发 出，会议于 2025 年 8 月 20 日上午 11：00 以通讯方式召开。本次会议应参与表决 董事 7 名，实参与表决董事 7 名，公司全体监事、高级管理人员列席了会议。会 议由董事长谢永富先生主持，会议的召开符合《中华人民共和国公司法》（以下 简称"《公司法》"）和《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 经充分的讨论和审议，会议以记名投票方式表决，形成如下决议： 投资规模、结项募投项目并将节余募集资金永久补充流动资金的议案》； 为满足未来对流动资金的需求，提高募集资金使用效率，降低公司财务成本， 根据募投项目建设进展及公司业务发展实际需要，公司拟计划将"甜叶菊专业提 取工厂建 ...